Tagged “pharmaceutical-marks”

Alkem Laboratories v. Numen Pharma (2026): ALCIPRO and ACIPROX are confusingly alike, and a 'bare possibility' of confusion suffices for medicines

On 8 June 2026 the Bombay High Court restrained Numen Pharma from using the mark 'ACIPROX', holding it phonetically similar to Alkem's registered 'ALCIPRO'. Justice Sharmila U. Deshmukh applied the heightened pharmaceutical confusion standard — the bare possibility of confusion is enough to injunct — and refused to dissect the rival marks syllable by syllable.